Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Herkinorin

From Wikipedia, the free encyclopedia
Opioid analgesic compound
Pharmaceutical compound
Herkinorin
Clinical data
ATC code
  • none
Legal status
Legal status
  • Legal/Uncontrolled
Identifiers
  • methyl (2S,4aR,6aR,7R,9S,10aS,10bR)-9-benzoyloxy-2-(furan-3-yl)-6a,10b-dimethyl-4,10-dioxo-2,4a,5,6,7,8,9,10a-octahydro-1H-benzo[f]isochromene-7-carboxylate
CAS Number
PubChemCID
ChemSpider
UNII
ChEMBL
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC28H30O8
Molar mass494.540 g·mol−1
3D model (JSmol)
  • O=C(OC)[C@H]3[C@@]4(CC[C@H]5C(=O)O[C@H](c1ccoc1)C[C@@]5([C@H]4C(=O)[C@@H](OC(=O)c2ccccc2)C3)C)C
  • InChI=1S/C28H30O8/c1-27-11-9-18-26(32)36-21(17-10-12-34-15-17)14-28(18,2)23(27)22(29)20(13-19(27)25(31)33-3)35-24(30)16-7-5-4-6-8-16/h4-8,10,12,15,18-21,23H,9,11,13-14H2,1-3H3/t18-,19-,20-,21-,23-,27-,28-/m0/s1 checkY
  • Key:PYDQMXRFUVDCHC-XAGHGKQISA-N checkY
 ☒NcheckY (what is this?)  (verify)

Herkinorin is anopioidanalgesic that is ananalogue of the natural productsalvinorin A. It was discovered in 2005 during structure-activity relationship studies intoneoclerodanediterpenes, the family of chemical compounds of which salvinorin A is a member.[1]

Unlike salvinorin A, which is a selectiveκ-opioid receptoragonist with no significantμ-opioid receptor affinity, herkinorin is predominantly a μ-opioid receptor agonist. Compared to salvinorin A, herkinorin has 47× loweraffinity for κ-opioid receptors (Ki = 90 nM vs Ki = 1.9 nM), and at least 25× higher affinity for μ-opioid receptors (Ki = 12 nM vs Ki >1000 nM), where it acts as a full agonist (IC50 = 0.5 μM, Emax = 130% vsDAMGO).[2][3] Herkinorin is asemi-synthetic compound, made fromsalvinorin B, which is most conveniently made from salvinorin A bydeacetylation, since, while both salvinorin A and salvinorin B are found in the plantSalvia divinorum, salvinorin A is present in larger quantities.[4]

A study in primates showed it to actperipherally as both a μ- and κ-opioid receptor agonist, with a fast onset of action. The study did not find any evidence ofcentral activity in primates and questions whether herkinorin's effects are due entirely to peripheral binding.[5] Unlike most μ-opioid receptor agonists, herkinorin does not promote the recruitment ofβ-arrestin 2 to the intracellular domain of the μ-opioid receptor, or inducereceptor internalization.[6] This means that herkinorin may not producetolerance anddependence in the same way as other opioids, although some development of tolerance through other mechanisms has been observed,[7] and some other analogues related to herkinorin can recruit β-arrestins.[8]

See also

[edit]

References

[edit]
  1. ^Harding WW, Tidgewell K, Byrd N, Cobb H, Dersch CM, Butelman ER, et al. (July 2005). "Neoclerodane diterpenes as a novel scaffold for mu opioid receptor ligands".Journal of Medicinal Chemistry.48 (15):4765–71.doi:10.1021/jm048963m.PMID 16033256.
  2. ^Tidgewell K, Harding WW, Lozama A, Cobb H, Shah K, Kannan P, et al. (June 2006). "Synthesis of salvinorin A analogues as opioid receptor probes".Journal of Natural Products.69 (6):914–8.Bibcode:2006JNAtP..69..914T.CiteSeerX 10.1.1.693.6345.doi:10.1021/np060094b.PMID 16792410.
  3. ^Holden KG, Tidgewell K, Marquam A, Rothman RB, Navarro H, Prisinzano TE (November 2007)."Synthetic studies of neoclerodane diterpenes from Salvia divinorum: exploration of the 1-position".Bioorganic & Medicinal Chemistry Letters.17 (22):6111–5.doi:10.1016/j.bmcl.2007.09.050.PMC 2111044.PMID 17904842.
  4. ^Tidgewell K, Harding WW, Schmidt M, Holden KG, Murry DJ, Prisinzano TE (October 2004). "A facile method for the preparation of deuterium labeled salvinorin A: synthesis of [2,2,2-2H3]-salvinorin A".Bioorganic & Medicinal Chemistry Letters.14 (20):5099–102.doi:10.1016/j.bmcl.2004.07.081.PMID 15380207.
  5. ^Butelman ER, Rus S, Simpson DS, Wolf A, Prisinzano TE, Kreek MJ (October 2008)."The effects of herkinorin, the first mu-selective ligand from a salvinorin A-derived scaffold, in a neuroendocrine biomarker assay in nonhuman primates".The Journal of Pharmacology and Experimental Therapeutics.327 (1):154–60.doi:10.1124/jpet.108.140079.PMC 2614932.PMID 18593955.
  6. ^Groer CE, Tidgewell K, Moyer RA, Harding WW, Rothman RB, Prisinzano TE, Bohn LM (February 2007)."An opioid agonist that does not induce mu-opioid receptor--arrestin interactions or receptor internalization".Molecular Pharmacology.71 (2):549–57.doi:10.1124/mol.106.028258.PMC 3926195.PMID 17090705.
  7. ^Xu H, Partilla JS, Wang X, Rutherford JM, Tidgewell K, Prisinzano TE, et al. (March 2007)."A comparison of noninternalizing (herkinorin) and internalizing (DAMGO) mu-opioid agonists on cellular markers related to opioid tolerance and dependence".Synapse (Submitted manuscript).61 (3):166–75.doi:10.1002/syn.20356.PMID 17152090.S2CID 23678472.
  8. ^Tidgewell K, Groer CE, Harding WW, Lozama A, Schmidt M, Marquam A, et al. (April 2008)."Herkinorin analogues with differential beta-arrestin-2 interactions".Journal of Medicinal Chemistry.51 (8):2421–31.doi:10.1021/jm701162g.PMC 2494883.PMID 18380425.
μ-opioid
(MOR)
Agonists
(abridged;
full list)
Antagonists
δ-opioid
(DOR)
Agonists
Antagonists
κ-opioid
(KOR)
Agonists
Antagonists
Nociceptin
(NOP)
Agonists
Antagonists
Others
Retrieved from "https://en.wikipedia.org/w/index.php?title=Herkinorin&oldid=1323701823"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp